Literature DB >> 22723063

The shrunken, bright cerebellum: a characteristic MRI finding in congenital disorders of glycosylation type 1a.

P Feraco1, M Mirabelli-Badenier, M Severino, M G Alpigiani, M Di Rocco, R Biancheri, A Rossi.   

Abstract

SUMMARY: CDG-1a is an early-onset neurodegenerative disease with selective hindbrain involvement and highly variable clinical presentation. We retrospectively reviewed the clinical records and MR imaging studies of 5 children (3 boys and 2 girls aged 12 days to 2 years at presentation) with molecularly confirmed CDG-1a. The cerebellum was hypoplastic at presentation in 4 cases, progressive bulk loss involved the cerebellum and the pons in all cases, and the cerebellar cortex and subcortical white matter were hyperintense on T2-weighted and FLAIR images in all. We conclude that CDG-1a likely results from a combination of cerebellar hypoplasia and atrophy. Cerebellar volume loss with diffuse T2/FLAIR hyperintensity seems to be a peculiar association in the field of cerebellar atrophies, and may be useful to address the differential diagnosis.

Entities:  

Mesh:

Year:  2012        PMID: 22723063      PMCID: PMC7965601          DOI: 10.3174/ajnr.A3151

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  11 in total

1.  Cerebellar atrophy: an important feature of carbohydrate deficient glycoprotein syndrome type 1.

Authors:  H Antoun; N Villeneuve; A Gelot; S Panisset; C Adamsbaum
Journal:  Pediatr Radiol       Date:  1999-03

2.  The hot cross bun sign.

Authors:  Arpan Shrivastava
Journal:  Radiology       Date:  2007-11       Impact factor: 11.105

3.  Congenital disorder of glycosylation type Ia: a clinicopathological report of a newborn infant with cerebellar pathology.

Authors:  E Aronica; A A M W van Kempen; M van der Heide; B T Poll-The; H J van Slooten; D Troost; J M Rozemuller-Kwakkel
Journal:  Acta Neuropathol       Date:  2005-02-16       Impact factor: 17.088

Review 4.  Differential diagnosis of cerebellar atrophy in childhood.

Authors:  Andrea Poretti; Nicole I Wolf; Eugen Boltshauser
Journal:  Eur J Paediatr Neurol       Date:  2007-09-14       Impact factor: 3.140

5.  Phosphomannomutase deficiency is the main cause of carbohydrate-deficient glycoprotein syndrome with type I isoelectrofocusing pattern of serum sialotransferrins.

Authors:  J Jaeken; J Artigas; R Barone; A Fiumara; T J de Koning; B T Poll-The; J F de Rijk-van Andel; G F Hoffmann; B Assmann; E Mayatepek; M Pineda; M A Vilaseca; J M Saudubray; B Schlüter; R Wevers; E Van Schaftingen
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

6.  Neurologic course of congenital disorders of glycosylation.

Authors:  P L Pearl; D Krasnewich
Journal:  J Child Neurol       Date:  2001-06       Impact factor: 1.987

7.  The normal brain stem from infancy to old age. A morphometric MRI study.

Authors:  R Raininko; T Autti; S L Vanhanen; A Ylikoski; T Erkinjuntti; P Santavuori
Journal:  Neuroradiology       Date:  1994-07       Impact factor: 2.804

Review 8.  A developmental and genetic classification for midbrain-hindbrain malformations.

Authors:  A James Barkovich; Kathleen J Millen; William B Dobyns
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

Review 9.  Cerebellum-small brain but large confusion: a review of selected cerebellar malformations and disruptions.

Authors:  Eugen Boltshauser
Journal:  Am J Med Genet A       Date:  2004-05-01       Impact factor: 2.802

10.  Cerebellar hypoplasia in children with the carbohydrate-deficient glycoprotein syndrome.

Authors:  P R Jensen; F J Hansen; F Skovby
Journal:  Neuroradiology       Date:  1995-05       Impact factor: 2.804

View more
  17 in total

1.  Longitudinal volumetric and 2D assessment of cerebellar atrophy in a large cohort of children with phosphomannomutase deficiency (PMM2-CDG).

Authors:  Víctor de Diego; Antonio F Martínez-Monseny; Jordi Muchart; Daniel Cuadras; Raquel Montero; Rafael Artuch; Celia Pérez-Cerdá; Belén Pérez; Belén Pérez-Dueñas; Andrea Poretti; Mercedes Serrano
Journal:  J Inherit Metab Dis       Date:  2017-03-24       Impact factor: 4.982

2.  Cerebellar atrophy with T2/FLAIR hyperintense cerebellar cortex: a new imaging phenotype of combined complex II/III deficiency.

Authors:  Ai Peng Tan; Carlos Robles; Kshitij Mankad
Journal:  Childs Nerv Syst       Date:  2018-02-27       Impact factor: 1.475

3.  PMM2-CDG and sensorineural hearing loss.

Authors:  Çiğdem Seher Kasapkara; Zeren Barış; Mustafa Kılıç; Deniz Yüksel; Lies Keldermans; Gert Matthijs; Jaak Jaeken
Journal:  J Inherit Metab Dis       Date:  2017-07-31       Impact factor: 4.982

Review 4.  A Proposed Clinical Classification and a Diagnostic Approach for Congenital Ataxias.

Authors:  Ivana Rocha Raslan; Orlando G Barsottini; José Luiz Pedroso
Journal:  Neurol Clin Pract       Date:  2021-06

5.  Neurological Consequences of Congenital Disorders of Glycosylation.

Authors:  Justyna Paprocka
Journal:  Adv Neurobiol       Date:  2023

6.  Subcutaneous fat pads on body MRI--an early sign of congenital disorder of glycosylation PMM2-CDG (CDG1a).

Authors:  Almundher A Al-Maawali; Elka Miller; Andreas Schulze; Grace Yoon; Susan I Blaser
Journal:  Pediatr Radiol       Date:  2013-09-15

Review 7.  Neurometabolic diseases of childhood.

Authors:  Zoltan Patay; Susan I Blaser; Andrea Poretti; Thierry A G M Huisman
Journal:  Pediatr Radiol       Date:  2015-09-07

Review 8.  Midbrain and hindbrain malformations: advances in clinical diagnosis, imaging, and genetics.

Authors:  Dan Doherty; Kathleen J Millen; A James Barkovich
Journal:  Lancet Neurol       Date:  2013-03-18       Impact factor: 44.182

Review 9.  Diagnostic Approach to Cerebellar Hypoplasia.

Authors:  Andrea Accogli; Nassima Addour-Boudrahem; Myriam Srour
Journal:  Cerebellum       Date:  2021-02-03       Impact factor: 3.847

10.  Terminology in morphological anomalies of the cerebellum does matter.

Authors:  Andrea Poretti; Eugen Boltshauser
Journal:  Cerebellum Ataxias       Date:  2015-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.